Anil Singhvi strategy April 18: Important levels to track in Nifty50, Nifty Bank today
Anil Singhvi Market Strategy: Zee Business Managing Editor Anil Singhvi shares his strategy for todays session on Dalal Street. Check out his take on key support and resistance levels for the Nifty and the Nifty Bank, and how he views the market.
Anil Singhvi Market Strategy: Zee Business Managing Editor Anil Singhvi sees support emerging at 22,000-22,075 levels and a strong buy zone at 21,825-21,950 levels for the headline Nifty50 index on Thursday, April 18.
For the Nifty Bank, he expects initial support to come in at 47,125-47,250 levels followed by a stronger support zone at 46,875-47,025 levels.
Here's how Anil Singhvi sums up the market setup:
- Global: Neutral
- FII: Negative
- DII: Positive
- F&O: Neutral
- Sentiment: Negative
- Trend: Positive
He expects a higher level for the headline index at 22,200-22,300 levels and a strong sell zone at 22,350-22,450 levels.
For the banking index, Singhvi expects a higher zone at 47,675-47,825 and a strong sell zone at 47,900-48,075 levels.
ANIL SINGHVI MARKET STRATEGY
- FII index longs at 44 per cent vs 49 per cent the previous day
- Nifty put-call ratio (PCR) at 0.76 vs 0.81
- Nifty Bank PCR at 0.85 vs 0.60
- Volatility index India VIX up 1.5 per cent at 12.64
Editor's take
- No news of fresh attacks in Iran-Israel conflict
- Israel PM warned of retaliatory action
- Crude oil at $88 a good sign
- Dow has stopped falling for two days
- Israel tensions are triggering limited reactions on Wall Street
- Wall Street market participants are more worried about delayed rate cuts
- FIIs withdrawing funds aggressively from Dalal Street
- Important for Nifty50 to hold 22,000 on a closing basis on the day of weekly F&O expiry
- Light positions in Nifty Bank following weekly expiry
What should traders do?
- Fears of war behind but markets not out of the woods yet
- Intraday and overnight swings to persist for now
- Traders should keep their positions light
What should investors do?
- Don't panic
- Keep tracking global developments closely; stay cautious
- If Israel retaliates, make sure not to panic and buy instead
- Any 1-2 per cent gap-down opening on Dalal Street should be used as an opportunity to buy aggressively
- Such situations have come and gone so many times
For existing long positions:
- Nifty intraday and closing stop loss at 22,000
- Nifty Bank intraday and closing stop loss at 47,250
For existing short positions:
- Nifty intraday and closing stop loss at 22,300
- Nifty Bank intraday stop loss at 47,800 and closing stop loss at 48,000
For new positions in Nifty:
- Aggressive traders can sell Nifty in the 22,250-22,350 range with a strict stop loss at 22,450 for targets of 22,200, 22,150, 22,125, 22,075, 22,025 and 22,000
- Aggressive traders can buy Nifty in the 21,950-22,075 range with a strict stop loss at 21,900 for targets of 22,150, 22,200, 22,250, 22,275 and 22,300
For new positions in Nifty Bank:
- Aggressive traders can sell Nifty Bank in the 47,775-47,900 range with a strict stop loss at 48,050 for targets of 47,725, 47,625, 47,500, 47,325 and 47,250
- Aggressive traders can buy Nifty Bank in the 47,125-47,250 range with a strict stop loss at 46,950 for targets of 47,400, 47,475, 47,600, 47,725, 47,775 and 47,875
F&O ban update
- New in ban: Vodafone Idea
- Out of ban: India Cements, Exide Industries
- Already in ban: Bandhan Bank, SAIL, GNFC, Metropolis, PEL, Balrampur Chini, Hindustan Copper, NALCO, ZEEL
Stocks of the day
Buy ICICI Lombard futures with a stop loss at Rs 1,633 for targets of Rs 1,680 and Rs 1,695
- Results better than estimates
- Jefferies has maintained a 'buy' rating with a target of Rs 1,950
Sell Tata Communications futures with a stop loss at Rs 1,915 for targets of Rs 1,860, Rs 1,848 and Rs 1,838
- Results below estimates
- Weak operating performance
- Margins down 1.5 per cent
Buy Biocon futures with a stop loss at Rs 260 for targets of Rs 272, Rs 278 and Rs 283
- The company has entered an exclusive licensing and supply agreement with Biomm
- The company will sell its products in Brazil
- The drug has a big market size of $3.7 billion in Brazil
- Biocon expected to get $500 million sales in next two years
Catch the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.